Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Avalo Therapeutics Inc. buy Stifel Nicolaus

Avalo Therapeutics Inc.
Start price
€0.041
25.03.25 / 50%
Target price
€33.31
25.03.26
Performance (%)
-
End price
-
26.03.26
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Avalo Therapeutics Inc. - - -
iShares Core DAX® 1,00 % 4,83 % 8,15 %
iShares Nasdaq 100 2,70 % -1,72 % 26,92 %
iShares Nikkei 225® 3,52 % -3,51 % 48,06 %
iShares S&P 500 1,77 % 1,27 % 23,58 %

Comments by Stifel_Nicolaus for this prediction

In the thread Avalo Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 33.314
Change
Ends at 25.03.26

Avalo Therapeutics, Inc. (NASDAQ: AVTX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $36.00 price target on the stock.
Ratings data for AVTX provided by MarketBeat

Stifel Nicolaus 
0
Report Share
25.03.25
In the thread Trading Avalo Therapeutics Inc.
Prediction Buy
Perf. (%) -
Target price 33.314
Change
Ends at 25.03.26

Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten

Stifel Nicolaus 
0
Report Share
26.03.26